• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特非那定在实验动物体内的代谢情况。

Metabolic disposition of terfenadine in laboratory animals.

作者信息

Leeson G A, Chan K Y, Knapp W C, Biedenbach S A, Wright G J, Okerholm R A

出版信息

Arzneimittelforschung. 1982;32(9a):1173-8.

PMID:6817764
Abstract

Alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1- piperidinebutanol (terfenadine, RMI 9918, Triludan, Teldane, resp.), a clinically effective antihistamine, with little or no central nervous system effects, was investigated in order to understand its metabolic disposition. These 14C-terfenadine studies were performed in laboratory animals, principally the rat, and also in beagle dog and monkey (Macaca mulatta). In all three species the fecal pathway of excretion was predominant with nearly all the elimination occurring within 24 h of administration. The data suggest that biliary excretion plays a prominent role. Tissue distribution studies indicated that the liver and lung, relative to other tissues, exhibited the highest concentrations of 14C-terfenadine equivalents. However, brain had low amounts of 14C-terfenadine which was in general agreement with the whole-body autoradiographic studies which did not show radioactivity in brain or spinal cord. The evidence suggests that terfenadine was metabolized rapidly with no terfenadine in urine or bile and small amounts in feces. Tissue concentrations of terfenadine were in the low nanogram range and peaked at 0.5-1.0 h with lung exhibiting the greatest and the brain sub-quantifiable amounts. The ratios of 14C-terfenadine eq/terfenadine were high and greatest in the liver and kidney. These studies demonstrated that terfenadine was readily absorbed and eliminated, virtually had undergone complete biotransformation and exhibited very low tissue concentrations per se.

摘要

α-[4-(1,1-二甲基乙基)苯基]-4-(羟基二苯甲基)-1-哌啶丁醇(特非那定,商品名分别为RMI 9918、Triludan、Teldane)是一种临床有效的抗组胺药,对中枢神经系统几乎没有影响。为了解其代谢情况,我们对其进行了研究。这些用14C标记特非那定的研究在实验动物身上进行,主要是大鼠,也包括比格犬和恒河猴(猕猴)。在这三种动物中,粪便排泄途径占主导地位,几乎所有的药物在给药后24小时内排出。数据表明胆汁排泄起了重要作用。组织分布研究表明,相对于其他组织,肝脏和肺中14C-特非那定等效物的浓度最高。然而,脑中14C-特非那定的含量很低,这与全身放射自显影研究结果基本一致,该研究未显示脑或脊髓中有放射性。证据表明特非那定代谢迅速,尿液或胆汁中没有特非那定,粪便中有少量。特非那定的组织浓度处于低纳克范围,在0.5 - 1.0小时达到峰值,肺中的浓度最高,而脑中的含量低于可检测量。肝脏和肾脏中14C-特非那定等效物与特非那定的比率很高且最大。这些研究表明特非那定易于吸收和消除,实际上已完全进行生物转化,其本身在组织中的浓度非常低。

相似文献

1
Metabolic disposition of terfenadine in laboratory animals.特非那定在实验动物体内的代谢情况。
Arzneimittelforschung. 1982;32(9a):1173-8.
2
Pharmacokinetics and biotransformation studies of terfenadine in man.特非那定在人体中的药代动力学及生物转化研究。
Arzneimittelforschung. 1982;32(9a):1185-90.
3
Terfenadine, the first non-sedating antihistamine.
Arzneimittelforschung. 1982;32(9a):1154-6.
4
Synthesis of terfenadine.
Arzneimittelforschung. 1982;32(9a):1157-9.
5
Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.脑内H1受体占据与抗组胺药镇静特性之间的关系。特非那定的评估。
Arzneimittelforschung. 1982;32(9a):1171-3.
6
Clinical studies of terfenadine in seasonal allergic rhinitis.
Arzneimittelforschung. 1982;32(9a):1204-5.
7
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
8
Preclinical safety studies with terfenadine.特非那定的临床前安全性研究。
Arzneimittelforschung. 1982;32(9a):1179-84.
9
Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.新型止泻药盐酸利达米定(WHR - 1142A)在大鼠和猴体内的药代动力学及处置情况
Arzneimittelforschung. 1978;28(8a):1477-80.
10
Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.环苯扎林在大鼠、狗、恒河猴和人体内的生理处置与代谢
Drug Metab Dispos. 1978 Nov-Dec;6(6):659-72.

引用本文的文献

1
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.人体和临床前动物模型中未变化药物的尿排泄检查:提高人类代谢不良的预测性。
Pharm Res. 2021 Jul;38(7):1139-1156. doi: 10.1007/s11095-021-03076-y. Epub 2021 Jul 12.
2
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment.阳离子两亲性抗组胺药在癌症治疗中的再利用。
EBioMedicine. 2016 Jul;9:130-139. doi: 10.1016/j.ebiom.2016.06.013. Epub 2016 Jun 7.
3
Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
评估兔浦肯野纤维试验作为评估人类药物诱发尖端扭转型室性心动过速风险的体外工具。
Drug Saf. 2006;29(3):237-54. doi: 10.2165/00002018-200629030-00007.
4
Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.通过正电子发射断层扫描测量单次口服组胺H1拮抗剂后人类大脑中组胺H1受体占有率。
Br J Pharmacol. 1995 Sep;116(1):1649-55. doi: 10.1111/j.1476-5381.1995.tb16386.x.
5
Effects of terfenadine on psychomotor performance. An overview.特非那定对精神运动表现的影响。综述。
Drug Saf. 1993 Apr;8(4):321-9. doi: 10.2165/00002018-199308040-00006.
6
Failure of terfenadine as an antipruritic agent in atopic dogs: results of a double-blinded, placebo-controlled study.特非那定作为异位性犬抗瘙痒剂的疗效不佳:一项双盲、安慰剂对照研究的结果。
Can Vet J. 1994 May;35(5):286-8.
7
Treatment of bronchial asthma with terfenadine; a randomized controlled trial.特非那定治疗支气管哮喘的随机对照试验。
Br J Clin Pharmacol. 1987 Dec;24(6):743-6. doi: 10.1111/j.1365-2125.1987.tb03240.x.
8
Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).H1受体拮抗剂(抗组胺药)的临床药代动力学
Clin Pharmacokinet. 1985 Nov-Dec;10(6):477-97. doi: 10.2165/00003088-198510060-00002.
9
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
Drugs. 1985 Jan;29(1):34-56. doi: 10.2165/00003495-198529010-00002.
10
Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy.特非那定。对其药理特性和治疗效果的最新综述。
Drugs. 1990 Apr;39(4):552-74. doi: 10.2165/00003495-199039040-00006.